Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXVQ0J
|
||||
| Drug Name |
4-[(3-Chlorophenyl)methyl]-2-{[(2R)-1-methyl-2-pyrrolidinyl]methyl}-1(2H)-phthalazinone
|
||||
| Synonyms |
CHEMBL1767146
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C21H22ClN3O
|
||||
| Canonical SMILES |
CN1CCC[C@@H]1CN2N=C(Cc3cccc(Cl)c3)c4ccccc4C2=O
|
||||
| InChI |
InChI=1S/C21H22ClN3O/c1-24-11-5-8-17(24)14-25-21(26)19-10-3-2-9-18(19)20(23-25)13-15-6-4-7-16(22)12-15/h2-4,6-7,9-10,12,17H,5,8,11,13-14H2,1H3/t17-/m1/s1
|
||||
| InChIKey |
YEFYNZHDZSJWCN-QGZVFWFLSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
| Histamine H1 receptor | Target Info | [1587926] | |||
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.